News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|March 22, 2017

Top Barriers to Colorectal Cancer Screening

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
CPAN begins the fourth quarter with a continued focus on its core mission: © stock.adobe.com.

2025 Quarter 3 – COA Patient Advocacy Network News Bulletin

By COA Patient Advocacy Network
October 2nd 2025
You don’t want to miss the upcoming CPAN Advocacy Chat, we hope you can join us!: © stock.adobe.com.

How PBMs Are Blocking Patient Access to Medication: A CPAN Advocacy Chat

By COA Patient Advocacy Network
October 2nd 2025
The FDA grants fast track status to alnodesertib in mCRC with ATM deficiency: © stock.adobe.com.

Alnodesertib Wins FDA Fast Track Status in ATM-Negative Colorectal Cancer

BySpencer Feldman
September 24th 2025
Image of colorectal cancer

A Patient's Guide to Understanding Colorectal Cancer

BySpencer Feldman
September 5th 2025
Picture of Dr. Usman Shah

Colorectal Cancer Screening Shifts as Cases Rise in Adults Under 50

BySpencer Feldman
September 5th 2025
Advertisement
Advertisement

Trending on CURE

1

FDA Grants Breakthrough Therapy Designation to Ficerafusp Alfa in Head and Neck Cancer

2

What the FDA Approval of Inluriyo Means for Patients With Breast Cancer

3

What Subcutaneous Keytruda Means for Patients With Melanoma

4

Early Detection and Misconceptions in Lung Cancer

5

Pelvic Health Therapy Helps Women Reclaim Comfort After Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.